Hangzhou Tigermed Consulting Co Ltd は1株あたり年間配当金が 0.7408 で、利回りは 0.00% です。配当金は 年次 に支払われ、最後の除息日は Jun 12, 2025 でした。
配当利回り
年間配当
除権日
0.00%
$0.7408
Jun 12, 2025
支払い頻度
支払率
年次
0.00%
配当履歴
除権日
現金額
記録日
支払日
Jun 12, 2025
$0.3245
Jun 13, 2025
Jul 11, 2025
Jun 7, 2024
$0.6237
Jun 11, 2024
Jul 18, 2024
May 25, 2023
$0.6156
May 29, 2023
Jul 7, 2023
May 24, 2022
$0.5796
May 25, 2022
Jun 20, 2022
配当チャート
HTMDF 配当
HTMDF 配当成長率(年間比)
Follow-Up Questions
Hangzhou Tigermed Consulting Co Ltdの現在の配当金と年間配当金はいくらですか?
Hangzhou Tigermed Consulting Co Ltdの配当性向は何ですか?
HTMDFの配当落ち日はいつですか?
Hangzhou Tigermed Consulting Co Ltdはどのくらいの頻度で配当金を支払いますか?
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
1株当たり利益(TTM)
--
配当利回り
--
時価総額
--
HTMDFとは何ですか?
Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 10,185 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.